Download PDF
Thromb Haemost 2004; 91(04): 839-840
DOI: 10.1055/s-0037-1614280
Letters to the Editor
Schattauer GmbH

Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin

Achim Obergfell
,
Heiner Langenfeld
,
Heiner Hopp
,
Udo Steigerwald
,
Ralf Grossmann
Further Information

Publication History

Received 08 September 2003

Accepted after revision 12 November 2003

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Lindhoff-Last E, Schinzel H, Erbe M. et al. Anticoagulation of pregnant women with mechanical heart valve prostheses. Z Kardiol 2001; 90 Suppl 6: 125-30.
    PubMedGoogle Scholar
  • 2 Montalescot G, Polle V, Collet JP. et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 101: 1083-6.
    CrossrefPubMedGoogle Scholar
  • 3 Arnaout MS, Kazma H, Khalil A. et al. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?. Clin Exp Obstet Gynecol 1998; 25: 101-4.
    PubMedGoogle Scholar
  • 4 Ezekowitz MD. Anticoagulation management of valve replacement patients. J Heart Valve Dis 2002; 11 Suppl 1: S56-60.
    PubMedGoogle Scholar
  • 5 Ginsberg JS, Chan WS, Bates SM. et al. Anticoagulation of pregnant women with mechanical heart valves. Arch totem Med 2003; 163: 694-8.
    PubMedGoogle Scholar
  • 6 Messmore Jr. HL, Kundur R, Wehrmacher W. et al. Anticoagulant fherapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin. Clin Appl Thromb Hemost 1999; 05: 73-7.
    CrossrefPubMedGoogle Scholar
  • 7 Golby AJ, Bush EC, DeRook FA. et al. Failure of high-dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve. Neurology 1992; 42: 2204-6.
    CrossrefPubMedGoogle Scholar
  • 8 Deitelzweig SB, Vanscoy GJ, Niccolai CS. et al. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Ann Pharmacother 2003; 37: 402-11.
    CrossrefPubMedGoogle Scholar
  • 9 Mahesh B, Evans S, Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation. J Heart Valve Dis 2002; 11: 745-50.
    PubMedGoogle Scholar
  • 10 Oles D, Berryessa R, Campbell K. et al. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: acase report. Perfusion 2001; 16: 159-64.
    CrossrefPubMedGoogle Scholar
  • 11 Lev-Ran O, Kramer A, Gurevitch J. et al. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000; 69: 264-5. discussion 265-6..
    PubMedGoogle Scholar
  • 12 Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol 2002; 25: 323-7.
    CrossrefPubMedGoogle Scholar
  • 13 Leyh RG, Fischer S, Ruhparwar A. et al. Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?. Eur J Cardiothorac Surg 2002; 21: 577-9.
    CrossrefPubMedGoogle Scholar
  • 14 Lee LH, Liauw PC, Ng AS. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996; 76: 628-30.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Barbour LA. Current concepts of anticoagulant therapy in pregnancy. Obstet Gynecol Clin North Am 1997; 24: 499-521.
    CrossrefPubMedGoogle Scholar